Поисковый запрос: (<.>S=ИРИНОТЕКАН<.>) |
Общее количество найденных документов : 359
Показаны документы с 1 по 20
|
|
1.
| Metabolic fate of irinotecin in humans: Correlation of glucuronidation with diarrhea // Cancer Res., 1994. Vol. 54, N 14.-С.3723-3725
|
2.
| Ch.M. Ch.M. Cancer du colon: Essais de phase II avec l'irinotecan // Concours med., 1994. Vol. 116, N 25-26.-С.2128
|
3.
| Metabolic fate of irinotecin in humans: Correlation of glucuronidation with diarrhea // Cancer Res., 1994. Vol. 54, N 14.-С.3723-3725
|
4.
| Metabolic fate of irinotecin in humans: Correlation of glucuronidation with diarrhea // Cancer Res., 1994. Vol. 54, N 14.-С.3723-3725
|
5.
| Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients // Cancer Res., 1994. Vol. 54, N 16.-С.4347-4354
|
6.
| Unger Neue Wirkstoffe und Wirkprinzipien in der Onkologie // Klinikarzt., 1994. Vol. 23, N 10.-С.389
|
7.
| Phase I clinical trial of irinotecan (CPT-11), 7-Ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindensine in advanced non-small cell lung cancer // Cancer Res., 1994. Vol. 54, N 10.-С.2636-2642
|
8.
| Irinotecan (СРТ-11) high-dose escalation using intensive high-dose loperamide to control diarrhea // J. Nat. Cancer Inst., 1994. Vol. 86, N 6.-С.446-449
|
9.
| Atsumi Metabolism of irinotecan to SN-38 in a tissue-isolated tumor model // Biol. and Pharm. Bull., 1995. Vol. 18, N 7.-С.1024-1026
|
10.
| Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase // Biochem. Pharmacol., 1996. Vol. 52, N 7.-С.1103-1111
|
11.
| Effects of paclitaxel, fotemustine, irinotecan, mitomycin C, ifosfamide and bleomycin on a highly malignant xeno-transplanted neuroblastoma // Cancer J., 1996. Vol. 9, N 6.-С.323-328
|
12.
| Effects of paclitaxel, fotemustine, irinotecan, mitomycin C, ifosfamide and bleomycin on a highly malignant xeno-transplanted neuroblastoma // Cancer J., 1996. Vol. 9, N 6.-С.323-328
|
13.
| Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase // Biochem. Pharmacol., 1996. Vol. 52, N 7.-С.1103-1111
|
14.
| Induction of tumor necrosis factor by a camptothecin derivative, irinotecan, in mice and human mononuclear cells // Anticancer Res., 1996. Vol. 16, N 5a.-С.2507-2512
|
15.
| Induction of tumor necrosis factor by a camptothecin derivative, irinotecan, in mice and human mononuclear cells // Anticancer Res., 1996. Vol. 16, N 5a.-С.2507-2512
|
16.
| Semsek Irinotecan: Neues Zytostatikum zur Behandlung des Kolonkarzinoms // Arzneimitteltherapie, 1996. Vol. 14, N 9.-С.260-265
|
17.
| Induction of tumor necrosis factor by a camptothecin derivative, irinotecan, in mice and human mononuclear cells // Anticancer Res., 1996. Vol. 16, N 5a.-С.2507-2512
|
18.
| Thromboxane A[2], released by the anti-tumour drug irinotecan, is a novel stimulator of Cl{-} secretion in isolated rat colon // J. Physiol., 1997. Vol. 505, N 1.-С.133-144
|
19.
| Sumiyoshi Клинико-фармакокинетическая оценка комбинации иринотекана с цисплатином у б-ных с нелеченым мелкоклеточным раком легкого // Hiroshima daigaku igaku zasshi, 1997. Vol. 45, N 3.-С.91-101
|
20.
| Kaneda Simultaneous determination of the lactone and carboxylate forms of 7-ethyl-1-hydroxycamptothecin (SN-38), the active metabolite of irinotecan (CPT-11), in rat plasma by high performance liquid chromatography // Biol. and Pharm. Bull., 1997. Vol. 20, N 7.-С.815-819
|
&uf('+1W2226#',v2226), ?>
|
|